Weekly tirzepatide for obesity and type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a once-weekly injection called tirzepatide to see if it helps people with type 2 diabetes and obesity control their blood sugar and lose weight. The goal is to see how well it works and how satisfied patients are with this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 80 years old and have type 2 diabetes.
- Your blood sugar is not well controlled, with an A1c of 7.0% or higher.
- You have obesity, meaning a BMI of 25 or higher (if Asian) or a waist size over 90 cm (men) or 80 cm (women).
- You have been taking oral diabetes pills for at least one year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tirzepatide, a weekly injection, can help people with type 1 diabetes who are also overweight or obese. The goal is to see if it improves blood sugar control and supports weight loss.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This study tests a medication called tirzepatide for people with type 1 diabetes who also have overweight or obesity. Tirzepatide may help with weight loss and blood sugar control, and you'll use a continuous glucose monitor throughout the study.
This study tests if tirzepatide, a medicine that helps lower blood sugar and manage weight, is safe and effective for people with type 1 diabetes who are overweight or have obesity. You must already use an automated insulin pump system.
This trial examines how well tirzepatide works for weight loss in people with obesity, and how it's actually used in daily life. It may be an option if you haven't tried other obesity treatments and don't have diabetes.
This trial tests the safety and effectiveness of tirzepatide, a once-weekly injection, for weight loss in people with obesity. It might be an option if you have a BMI of 27 or higher with weight-related health problems, or a BMI of 35 or higher, and live in or near Asunción, Paraguay.
Hear when a new Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.